business
ADHD pill maker’s earnings soar on prescription surge
Shire Plc reported a 20% increase in first-quarter earnings per share as doctors prescribed more Vyvanse, a pill for ADHD that it expects will bring in more than $1bn (€762m) this year.
A COMPREHENSIVE SERIES OF ARTICLES ON THIS TOPIC